Clearline Capital’s Anterix ATEX Stock Holding History

Clearline Capital’s Portfolio ATEX Stock Details ATEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-100,000	Closed	-$4.21M	–	45
2015 Q2	$4.21M	Buy	100,000 +12,200	+14%	+$576K	0.59%	42
2015 Q1	$4.39M	Buy	+87,800	New	+$4.27M	0.66%	40

Other funds holding ATEX

Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SAM

Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Clearline Capital's ATEX Position: Q3 2015 in Review

Clearline Capital sold out of Anterix (ATEX) in Q3 2015, closing a stake of 100,000 shares — an estimated $4.21M sold.

Clearline Capital first reported a position in ATEX in Q1 2015 and held it in 2 quarters. The position peaked at $4.39M in Q1 2015. 48 funds tracked by Wall St. Rank hold ATEX as of Q3 2015.

Clearline Capital reported no remaining Anterix position as of Q3 2015 after selling out during the quarter.
Clearline Capital sold 100,000 Anterix shares in Q3 2015, an estimated $4.21M.
Clearline Capital first reported a position in Anterix in Q1 2015 and held it in 2 quarters.
Clearline Capital's Anterix position peaked at $4.39M in Q1 2015.
48 funds tracked by Wall St. Rank held Anterix as of Q3 2015.

Based on Clearline Capital's 13F filing for Q3 2015, filed 16 Nov 2015.